Cytokinetics Inc (CYTK)
51.48
-0.34
(-0.66%)
USD |
NASDAQ |
Nov 04, 16:00
51.50
+0.02
(+0.04%)
After-Hours: 20:00
Cytokinetics Total Assets (Quarterly): 1.524B for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.524B |
| March 31, 2024 | 808.08M |
| December 31, 2023 | 824.32M |
| September 30, 2023 | 740.61M |
| June 30, 2023 | 779.90M |
| March 31, 2023 | 889.82M |
| December 31, 2022 | 1.015B |
| September 30, 2022 | 1.076B |
| June 30, 2022 | 771.72M |
| March 31, 2022 | 856.25M |
| December 31, 2021 | 841.32M |
| September 30, 2021 | 827.54M |
| June 30, 2021 | 564.30M |
| March 31, 2021 | 577.06M |
| December 31, 2020 | 533.80M |
| September 30, 2020 | 474.11M |
| June 30, 2020 | 232.50M |
| March 31, 2020 | 256.58M |
| December 31, 2019 | 289.81M |
| September 30, 2019 | 187.39M |
| June 30, 2019 | 198.22M |
| March 31, 2019 | 198.61M |
| December 31, 2018 | 211.18M |
| September 30, 2018 | 230.28M |
| June 30, 2018 | 247.24M |
| Date | Value |
|---|---|
| March 31, 2018 | 279.93M |
| December 31, 2017 | 294.81M |
| September 30, 2017 | 326.31M |
| June 30, 2017 | 340.63M |
| March 31, 2017 | 265.37M |
| December 31, 2016 | 170.14M |
| September 30, 2016 | 158.17M |
| June 30, 2016 | 106.16M |
| March 31, 2016 | 113.22M |
| December 31, 2015 | 115.24M |
| September 30, 2015 | 102.20M |
| June 30, 2015 | 112.71M |
| March 31, 2015 | 122.21M |
| December 31, 2014 | 132.97M |
| September 30, 2014 | 87.18M |
| June 30, 2014 | 96.14M |
| March 31, 2014 | 107.28M |
| December 31, 2013 | 83.19M |
| September 30, 2013 | 88.01M |
| June 30, 2013 | 94.56M |
| March 31, 2013 | 64.69M |
| December 31, 2012 | 77.55M |
| September 30, 2012 | 85.34M |
| June 30, 2012 | 94.08M |
| March 31, 2012 | 46.53M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
232.50M
Minimum
Jun 2020
1.524B
Maximum
Jun 2024
730.64M
Average
779.90M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 4.205B |
| Biomarin Pharmaceutical Inc | 6.851B |
| Catalyst Pharmaceuticals Inc | 706.36M |
| Sarepta Therapeutics Inc | 3.424B |
| Ocugen Inc | 40.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.415B |
| Shareholders Equity (Quarterly) | 108.55M |
| Debt to Equity Ratio | 6.034 |
| Current Ratio | 10.39 |
| Net Debt Paydown Yield | -0.14% |